 | • レポートコード：QYR2104Z0991 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、乳がん用リキッドバイオプシーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（循環腫瘍細胞（CTC）、無細胞DNA（CfDNA）、細胞外小胞（EV）、その他循環バイオマーカー）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・乳がん用リキッドバイオプシーの市場動向 ・企業の競争状況、市場シェア ・乳がん用リキッドバイオプシーの種類別市場規模（循環腫瘍細胞（CTC）、無細胞DNA（CfDNA）、細胞外小胞（EV）、その他循環バイオマーカー） ・乳がん用リキッドバイオプシーの用途別市場規模（病院、診断センター、研究所） ・乳がん用リキッドバイオプシーの北米市場規模2016-2027（アメリカ、カナダ） ・乳がん用リキッドバイオプシーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・乳がん用リキッドバイオプシーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・乳がん用リキッドバイオプシーの中南米市場規模2016-2027（メキシコ、ブラジル） ・乳がん用リキッドバイオプシーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（QIAGEN、Roche Diagnostics、Bio-Rad Laboratories、Myriad Genetics、Menarini Silicon Biosystems、Genomic Health、Thermo Fisher Scientific、Illumina、Biocept、Trovagene、Guardant Health、RainDance Technologies、MDx Health） ・結論 |
Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.
Market Analysis and Insights: Global Breast Cancer Liquid Biopsy Market
The global Breast Cancer Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breast Cancer Liquid Biopsy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breast Cancer Liquid Biopsy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breast Cancer Liquid Biopsy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breast Cancer Liquid Biopsy market.
Global Breast Cancer Liquid Biopsy Scope and Market Size
Breast Cancer Liquid Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Liquid Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Circulating Tumor Cells (CTCs)
Cell-Free DNA (CfDNA)
Extracellular Vesicles (EVs)
Other Circulating Biomarkers
Segment by Application
Hospitals
Diagnostic Centers
Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
QIAGEN
Roche Diagnostics
Bio-Rad Laboratories
Myriad Genetics
Menarini Silicon Biosystems
Genomic Health
Thermo Fisher Scientific
Illumina
Biocept
Myriad Genetics
Menarini Silicon Biosystems
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Circulating Tumor Cells (CTCs)
1.2.3 Cell-Free DNA (CfDNA)
1.2.4 Extracellular Vesicles (EVs)
1.2.5 Other Circulating Biomarkers
1.3 Market by Application
1.3.1 Global Breast Cancer Liquid Biopsy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Liquid Biopsy Market Perspective (2016-2027)
2.2 Breast Cancer Liquid Biopsy Growth Trends by Regions
2.2.1 Breast Cancer Liquid Biopsy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Breast Cancer Liquid Biopsy Historic Market Share by Regions (2016-2021)
2.2.3 Breast Cancer Liquid Biopsy Forecasted Market Size by Regions (2022-2027)
2.3 Breast Cancer Liquid Biopsy Industry Dynamic
2.3.1 Breast Cancer Liquid Biopsy Market Trends
2.3.2 Breast Cancer Liquid Biopsy Market Drivers
2.3.3 Breast Cancer Liquid Biopsy Market Challenges
2.3.4 Breast Cancer Liquid Biopsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue
3.1.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue (2016-2021)
3.1.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Players (2016-2021)
3.2 Global Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Liquid Biopsy Revenue
3.4 Global Breast Cancer Liquid Biopsy Market Concentration Ratio
3.4.1 Global Breast Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Liquid Biopsy Revenue in 2020
3.5 Breast Cancer Liquid Biopsy Key Players Head office and Area Served
3.6 Key Players Breast Cancer Liquid Biopsy Product Solution and Service
3.7 Date of Enter into Breast Cancer Liquid Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Liquid Biopsy Breakdown Data by Type
4.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Type (2016-2021)
4.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2022-2027)
5 Breast Cancer Liquid Biopsy Breakdown Data by Application
5.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Application (2016-2021)
5.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Breast Cancer Liquid Biopsy Market Size (2016-2027)
6.2 North America Breast Cancer Liquid Biopsy Market Size by Type
6.2.1 North America Breast Cancer Liquid Biopsy Market Size by Type (2016-2021)
6.2.2 North America Breast Cancer Liquid Biopsy Market Size by Type (2022-2027)
6.2.3 North America Breast Cancer Liquid Biopsy Market Size by Type (2016-2027)
6.3 North America Breast Cancer Liquid Biopsy Market Size by Application
6.3.1 North America Breast Cancer Liquid Biopsy Market Size by Application (2016-2021)
6.3.2 North America Breast Cancer Liquid Biopsy Market Size by Application (2022-2027)
6.3.3 North America Breast Cancer Liquid Biopsy Market Size by Application (2016-2027)
6.4 North America Breast Cancer Liquid Biopsy Market Size by Country
6.4.1 North America Breast Cancer Liquid Biopsy Market Size by Country (2016-2021)
6.4.2 North America Breast Cancer Liquid Biopsy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Breast Cancer Liquid Biopsy Market Size (2016-2027)
7.2 Europe Breast Cancer Liquid Biopsy Market Size by Type
7.2.1 Europe Breast Cancer Liquid Biopsy Market Size by Type (2016-2021)
7.2.2 Europe Breast Cancer Liquid Biopsy Market Size by Type (2022-2027)
7.2.3 Europe Breast Cancer Liquid Biopsy Market Size by Type (2016-2027)
7.3 Europe Breast Cancer Liquid Biopsy Market Size by Application
7.3.1 Europe Breast Cancer Liquid Biopsy Market Size by Application (2016-2021)
7.3.2 Europe Breast Cancer Liquid Biopsy Market Size by Application (2022-2027)
7.3.3 Europe Breast Cancer Liquid Biopsy Market Size by Application (2016-2027)
7.4 Europe Breast Cancer Liquid Biopsy Market Size by Country
7.4.1 Europe Breast Cancer Liquid Biopsy Market Size by Country (2016-2021)
7.4.2 Europe Breast Cancer Liquid Biopsy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size (2016-2027)
8.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type
8.2.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type (2016-2027)
8.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application
8.3.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application (2016-2027)
8.4 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region
8.4.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Breast Cancer Liquid Biopsy Market Size (2016-2027)
9.2 Latin America Breast Cancer Liquid Biopsy Market Size by Type
9.2.1 Latin America Breast Cancer Liquid Biopsy Market Size by Type (2016-2021)
9.2.2 Latin America Breast Cancer Liquid Biopsy Market Size by Type (2022-2027)
9.2.3 Latin America Breast Cancer Liquid Biopsy Market Size by Type (2016-2027)
9.3 Latin America Breast Cancer Liquid Biopsy Market Size by Application
9.3.1 Latin America Breast Cancer Liquid Biopsy Market Size by Application (2016-2021)
9.3.2 Latin America Breast Cancer Liquid Biopsy Market Size by Application (2022-2027)
9.3.3 Latin America Breast Cancer Liquid Biopsy Market Size by Application (2016-2027)
9.4 Latin America Breast Cancer Liquid Biopsy Market Size by Country
9.4.1 Latin America Breast Cancer Liquid Biopsy Market Size by Country (2016-2021)
9.4.2 Latin America Breast Cancer Liquid Biopsy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size (2016-2027)
10.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type
10.2.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2016-2027)
10.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application
10.3.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2016-2027)
10.4 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country
10.4.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 QIAGEN
11.1.1 QIAGEN Company Details
11.1.2 QIAGEN Business Overview
11.1.3 QIAGEN Breast Cancer Liquid Biopsy Introduction
11.1.4 QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.1.5 QIAGEN Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Details
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Introduction
11.2.4 Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.2.5 Roche Diagnostics Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Introduction
11.3.4 Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Details
11.4.2 Myriad Genetics Business Overview
11.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Introduction
11.4.4 Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.4.5 Myriad Genetics Recent Development
11.5 Menarini Silicon Biosystems
11.5.1 Menarini Silicon Biosystems Company Details
11.5.2 Menarini Silicon Biosystems Business Overview
11.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Introduction
11.5.4 Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.5.5 Menarini Silicon Biosystems Recent Development
11.6 Genomic Health
11.6.1 Genomic Health Company Details
11.6.2 Genomic Health Business Overview
11.6.3 Genomic Health Breast Cancer Liquid Biopsy Introduction
11.6.4 Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.6.5 Genomic Health Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Details
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Introduction
11.7.4 Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Illumina
11.8.1 Illumina Company Details
11.8.2 Illumina Business Overview
11.8.3 Illumina Breast Cancer Liquid Biopsy Introduction
11.8.4 Illumina Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.8.5 Illumina Recent Development
11.9 Biocept
11.9.1 Biocept Company Details
11.9.2 Biocept Business Overview
11.9.3 Biocept Breast Cancer Liquid Biopsy Introduction
11.9.4 Biocept Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.9.5 Biocept Recent Development
11.10 Trovagene
11.10.1 Trovagene Company Details
11.10.2 Trovagene Business Overview
11.10.3 Trovagene Breast Cancer Liquid Biopsy Introduction
11.10.4 Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.10.5 Trovagene Recent Development
11.11 Guardant Health
11.11.1 Guardant Health Company Details
11.11.2 Guardant Health Business Overview
11.11.3 Guardant Health Breast Cancer Liquid Biopsy Introduction
11.11.4 Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.11.5 Guardant Health Recent Development
11.12 RainDance Technologies
11.12.1 RainDance Technologies Company Details
11.12.2 RainDance Technologies Business Overview
11.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Introduction
11.12.4 RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.12.5 RainDance Technologies Recent Development
11.13 MDx Health
11.13.1 MDx Health Company Details
11.13.2 MDx Health Business Overview
11.13.3 MDx Health Breast Cancer Liquid Biopsy Introduction
11.13.4 MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021)
11.13.5 MDx Health Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Circulating Tumor Cells (CTCs)
Table 3. Key Players of Cell-Free DNA (CfDNA)
Table 4. Key Players of Extracellular Vesicles (EVs)
Table 5. Key Players of Other Circulating Biomarkers
Table 6. Global Breast Cancer Liquid Biopsy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Breast Cancer Liquid Biopsy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Breast Cancer Liquid Biopsy Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Breast Cancer Liquid Biopsy Market Share by Regions (2016-2021)
Table 10. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Breast Cancer Liquid Biopsy Market Share by Regions (2022-2027)
Table 12. Breast Cancer Liquid Biopsy Market Trends
Table 13. Breast Cancer Liquid Biopsy Market Drivers
Table 14. Breast Cancer Liquid Biopsy Market Challenges
Table 15. Breast Cancer Liquid Biopsy Market Restraints
Table 16. Global Breast Cancer Liquid Biopsy Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Breast Cancer Liquid Biopsy Market Share by Players (2016-2021)
Table 18. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Liquid Biopsy as of 2020)
Table 19. Ranking of Global Top Breast Cancer Liquid Biopsy Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Breast Cancer Liquid Biopsy Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Breast Cancer Liquid Biopsy Product Solution and Service
Table 23. Date of Enter into Breast Cancer Liquid Biopsy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2016-2021)
Table 27. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Breast Cancer Liquid Biopsy Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Breast Cancer Liquid Biopsy Revenue Market Share by Application (2016-2021)
Table 31. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Breast Cancer Liquid Biopsy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Breast Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Breast Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Breast Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Breast Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Breast Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Breast Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million)
Table 63. QIAGEN Company Details
Table 64. QIAGEN Business Overview
Table 65. QIAGEN Breast Cancer Liquid Biopsy Product
Table 66. QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 67. QIAGEN Recent Development
Table 68. Roche Diagnostics Company Details
Table 69. Roche Diagnostics Business Overview
Table 70. Roche Diagnostics Breast Cancer Liquid Biopsy Product
Table 71. Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 72. Roche Diagnostics Recent Development
Table 73. Bio-Rad Laboratories Company Details
Table 74. Bio-Rad Laboratories Business Overview
Table 75. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product
Table 76. Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 77. Bio-Rad Laboratories Recent Development
Table 78. Myriad Genetics Company Details
Table 79. Myriad Genetics Business Overview
Table 80. Myriad Genetics Breast Cancer Liquid Biopsy Product
Table 81. Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 82. Myriad Genetics Recent Development
Table 83. Menarini Silicon Biosystems Company Details
Table 84. Menarini Silicon Biosystems Business Overview
Table 85. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product
Table 86. Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 87. Menarini Silicon Biosystems Recent Development
Table 88. Genomic Health Company Details
Table 89. Genomic Health Business Overview
Table 90. Genomic Health Breast Cancer Liquid Biopsy Product
Table 91. Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 92. Genomic Health Recent Development
Table 93. Thermo Fisher Scientific Company Details
Table 94. Thermo Fisher Scientific Business Overview
Table 95. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product
Table 96. Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 97. Thermo Fisher Scientific Recent Development
Table 98. Illumina Company Details
Table 99. Illumina Business Overview
Table 100. Illumina Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 101. Illumina Recent Development
Table 102. Biocept Company Details
Table 103. Biocept Business Overview
Table 104. Biocept Breast Cancer Liquid Biopsy Product
Table 105. Biocept Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 106. Biocept Recent Development
Table 107. Trovagene Company Details
Table 108. Trovagene Business Overview
Table 109. Trovagene Breast Cancer Liquid Biopsy Product
Table 110. Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 111. Trovagene Recent Development
Table 112. Guardant Health Company Details
Table 113. Guardant Health Business Overview
Table 114. Guardant Health Breast Cancer Liquid Biopsy Product
Table 115. Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 116. Guardant Health Recent Development
Table 117. RainDance Technologies Company Details
Table 118. RainDance Technologies Business Overview
Table 119. RainDance Technologies Breast Cancer Liquid Biopsy Product
Table 120. RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 121. RainDance Technologies Recent Development
Table 122. MDx Health Company Details
Table 123. MDx Health Business Overview
Table 124. MDx Health Breast Cancer Liquid Biopsy Product
Table 125. MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million)
Table 126. MDx Health Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breast Cancer Liquid Biopsy Market Share by Type: 2020 VS 2027
Figure 2. Circulating Tumor Cells (CTCs) Features
Figure 3. Cell-Free DNA (CfDNA) Features
Figure 4. Extracellular Vesicles (EVs) Features
Figure 5. Other Circulating Biomarkers Features
Figure 6. Global Breast Cancer Liquid Biopsy Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Laboratories Case Studies
Figure 10. Breast Cancer Liquid Biopsy Report Years Considered
Figure 11. Global Breast Cancer Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Breast Cancer Liquid Biopsy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Breast Cancer Liquid Biopsy Market Share by Regions: 2020 VS 2027
Figure 14. Global Breast Cancer Liquid Biopsy Market Share by Regions (2022-2027)
Figure 15. Global Breast Cancer Liquid Biopsy Market Share by Players in 2020
Figure 16. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Liquid Biopsy as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Breast Cancer Liquid Biopsy Revenue in 2020
Figure 18. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2016-2021)
Figure 19. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2022-2027)
Figure 20. North America Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Breast Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 22. North America Breast Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 23. North America Breast Cancer Liquid Biopsy Market Share by Country (2016-2027)
Figure 24. United States Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Breast Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 28. Europe Breast Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 29. Europe Breast Cancer Liquid Biopsy Market Share by Country (2016-2027)
Figure 30. Germany Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Breast Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Breast Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Breast Cancer Liquid Biopsy Market Share by Region (2016-2027)
Figure 40. China Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Breast Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 48. Latin America Breast Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 49. Latin America Breast Cancer Liquid Biopsy Market Share by Country (2016-2027)
Figure 50. Mexico Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Breast Cancer Liquid Biopsy Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Breast Cancer Liquid Biopsy Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Breast Cancer Liquid Biopsy Market Share by Country (2016-2027)
Figure 56. Turkey Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. QIAGEN Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 60. Roche Diagnostics Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 61. Bio-Rad Laboratories Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 62. Myriad Genetics Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 63. Menarini Silicon Biosystems Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 64. Genomic Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 66. Illumina Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 67. Biocept Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 68. Trovagene Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 69. Guardant Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 70. RainDance Technologies Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 71. MDx Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のリキッドバイオプシー用循環バイオマーカー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Circulating Biomarker for Liquid Biopsy Market The global Circulating Biomarker for Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…- 世界の循環腫瘍細胞（CTC）予後技術市場規模・現状・予測（2021年-2027年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
- 世界の循環腫瘍細胞（CTC）・がん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 世界の肺がん用リキッドバイオプシー市場規模・現状・予測（2021年-2027年） Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. CtDNA and CTCs have been the most explored technologies for commercial applications up to the present time. Market Analysis and Insigh…
- 世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年） Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potenti…